膵がん
A Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Chemoradiation Following Induction Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.Thakur V, Khosla D, Singh G, et al. J Gastrointest …
Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma: An Academic Gastrointestinal Cancer Consortium (AGICC) Study.Cohen DJ, Goldberg JD, Leichman L, et al. Oncologist. 2025 Sep 16:oyaf271. doi: 10.1093/…
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial. Janssen QP, van Dam JL, van Bekkum M…
Radiotherapy of pancreatic cancers: 2025 update.Bertrand-Chevrier M, Riou O, Orthuon A, et al. Cancer Radiother. 2025 Aug 20;29(7-8):104716. doi: 10.1016/j.canrad.2025.104716. Epub ahead of print. PMID: 40839896. 【概要】 ・術後はmFOLFIRIN…
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.Fietkau R, Ghadimi M, Grützmann R, et al. J Clin Oncol. 2025 Aug 13:J…
Prospective Phase II Clinical Trial of Carbon Ion Radiotherapy Combined with Chemotherapy for Locally Advanced Pancreatic Carcinoma.Zhang G, Cai X, Cao H,et al. Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04522-5. DOI: 10.1016/j…
